• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简明综述:犬糖尿病作为创新再生医学方法的转化模型。

Concise Review: Canine Diabetes Mellitus as a Translational Model for Innovative Regenerative Medicine Approaches.

机构信息

Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.

Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Sydney, Australia.

出版信息

Stem Cells Transl Med. 2019 May;8(5):450-455. doi: 10.1002/sctm.18-0163. Epub 2019 Feb 5.

DOI:10.1002/sctm.18-0163
PMID:30719867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6476992/
Abstract

Diabetes mellitus (DM) is a common spontaneous endocrine disorder in dogs, which is defined by persistent hyperglycemia and insulin deficiency. Like type 1 diabetes (T1D) in people, canine DM is a complex and multifactorial disease in which genomic and epigenomic factors interact with environmental cues to induce pancreatic β-cell loss and insulin deficiency, although the pathogenesis of canine DM is poorly defined and the role of autoimmunity is further controversial. Both diseases are incurable and require life-long exogenous insulin therapy to maintain glucose homeostasis. Human pancreatic islet physiology, size, and cellular composition is further mirrored by canine islets. Although pancreatic or isolated islets transplantation are the only clinically validated methods to achieve long-term normoglycemia and insulin independence, their availability does not meet the clinical need; they target a small portion of patients and have significant potential adverse effects. Therefore, providing a new source for β-cell replacement is an unmet need. Naturally occurring DM in pet dogs, as a translational platform, is an untapped resource for various regenerative medicine applications that may offer some unique advantages given dogs' large size, longevity, heterogenic genetic background, similarity to human physiology and pathology, and long-term clinical management. In this review, we outline different strategies for curative approaches, animal models used, and consider the value of canine DM as a translational animal/disease model for T1D in people. Stem Cells Translational Medicine 2019;8:450-455.

摘要

糖尿病(DM)是犬常见的自发性内分泌紊乱疾病,其特征为持续高血糖和胰岛素缺乏。与人类 1 型糖尿病(T1D)一样,犬 DM 是一种复杂的多因素疾病,其中基因组和表观基因组因素与环境线索相互作用,导致胰岛 β 细胞损失和胰岛素缺乏,尽管犬 DM 的发病机制尚未明确,自身免疫的作用仍存在争议。这两种疾病均无法治愈,需要终身外源性胰岛素治疗来维持血糖稳态。人类胰岛的生理学、大小和细胞组成与犬胰岛进一步相似。虽然胰腺或分离胰岛移植是实现长期正常血糖和胰岛素独立性的唯一经临床验证的方法,但它们的可用性无法满足临床需求;它们仅适用于一小部分患者,且具有显著的潜在不良反应。因此,提供新的β细胞替代来源是一个未满足的需求。宠物犬中自然发生的 DM 作为一种转化平台,是各种再生医学应用的未开发资源,鉴于犬体型较大、寿命较长、遗传背景多样化、与人类生理学和病理学相似,以及长期临床管理,这些应用可能具有一些独特的优势。在这篇综述中,我们概述了不同的治疗策略、所用动物模型,并考虑了犬 DM 作为人类 T1D 转化动物/疾病模型的价值。Stem Cells Translational Medicine 2019;8:450-455.

相似文献

1
Concise Review: Canine Diabetes Mellitus as a Translational Model for Innovative Regenerative Medicine Approaches.简明综述:犬糖尿病作为创新再生医学方法的转化模型。
Stem Cells Transl Med. 2019 May;8(5):450-455. doi: 10.1002/sctm.18-0163. Epub 2019 Feb 5.
2
Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using "Neo-Islets," aggregates of adipose stem and pancreatic islet cells (INAD 012-776).用“Neo-Islets”(脂肪干细胞和胰岛细胞的聚集物)对宠物犬的胰岛素依赖型糖尿病进行腹腔内治疗的中期报告(INAD 012-776)。
PLoS One. 2019 Sep 19;14(9):e0218688. doi: 10.1371/journal.pone.0218688. eCollection 2019.
3
Generating β-cells in vitro: progress towards a Holy Grail.体外生成β细胞:迈向圣杯的进展。
Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):112-7. doi: 10.1097/MED.0b013e32835edb4c.
4
Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.人类诱导多能干细胞在糖尿病治疗中的应用及潜在障碍
Adv Exp Med Biol. 2019;1144:25-35. doi: 10.1007/5584_2018_305.
5
Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.糖尿病的再生医学:人类多能干细胞在体外分化为功能性β细胞及其向临床转化的设想历程。
Vitam Horm. 2014;95:223-48. doi: 10.1016/B978-0-12-800174-5.00009-0.
6
Validity of animal models of type 1 diabetes, and strategies to enhance their utility in translational research.1 型糖尿病动物模型的有效性,以及提高其在转化研究中应用的策略。
Eur J Pharmacol. 2015 Jul 15;759:221-30. doi: 10.1016/j.ejphar.2015.02.054. Epub 2015 Mar 24.
7
Generation of Human Stem Cell-Derived Pancreatic Organoids (POs) for Regenerative Medicine.用于再生医学的人类干细胞衍生的胰腺类器官(POs)的生成。
Adv Exp Med Biol. 2020;1212:179-220. doi: 10.1007/5584_2019_340.
8
Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.调节胰岛应激轴作为糖尿病一种新的潜在治疗靶点。
Vitam Horm. 2014;95:195-222. doi: 10.1016/B978-0-12-800174-5.00008-9.
9
Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?人类、非肥胖糖尿病(NOD)小鼠和犬类自身免疫性糖尿病的比较发病机制:1型糖尿病的一个有价值的动物模型被忽视了吗?
Diabetes. 2017 Jun;66(6):1443-1452. doi: 10.2337/db16-1551.
10
FGF-2b and h-PL Transform Duct and Non-Endocrine Human Pancreatic Cells into Endocrine Insulin Secreting Cells by Modulating Differentiating Genes.FGF-2b 和 h-PL 通过调节分化基因将人胰腺导管和非内分泌细胞转化为内分泌胰岛素分泌细胞。
Int J Mol Sci. 2017 Oct 25;18(11):2234. doi: 10.3390/ijms18112234.

引用本文的文献

1
Improved Differentiation Towards Insulin Producing Beta-Cells Derived from Healthy Canine Pancreatic Ductal Organoids.源自健康犬胰腺导管类器官的胰岛素分泌β细胞的分化改善
Vet Sci. 2025 Apr 13;12(4):362. doi: 10.3390/vetsci12040362.
2
Development and validation of a chronic diagnosis inventory that enables reliable documentation of canine multimorbidity in the Dog Aging Project.犬类衰老项目中一种慢性诊断清单的开发与验证,该清单能够可靠记录犬类的多种疾病情况。
Am J Vet Res. 2025 Mar 31;86(6). doi: 10.2460/ajvr.25.02.0038. Print 2025 Jun 1.
3
Painful Diabetic Neuropathy: Sex-Specific Mechanisms and Differences from Animal Models to Clinical Outcomes.疼痛性糖尿病神经病变:性别特异性机制以及从动物模型到临床结果的差异
Cells. 2024 Dec 7;13(23):2024. doi: 10.3390/cells13232024.
4
Generation of Insulin-Producing Cells from Canine Bone Marrow-Derived Mesenchymal Stem Cells: A Preliminary Study.从犬骨髓间充质干细胞生成胰岛素分泌细胞:一项初步研究。
Vet Sci. 2024 Aug 18;11(8):380. doi: 10.3390/vetsci11080380.
5
Ex Vivo Immune Function and Modulatory Effects of Calcitriol in Dogs with Naturally Occurring Diabetes Mellitus.骨化三醇对自然发生糖尿病犬的体外免疫功能及调节作用
Vet Sci. 2024 Apr 28;11(5):193. doi: 10.3390/vetsci11050193.
6
Canine diabetes mellitus demonstrates multiple markers of chronic inflammation including Th40 cell increases and elevated systemic-immune inflammation index, consistent with autoimmune dysregulation.犬糖尿病表现出多种慢性炎症标志物,包括Th40细胞增加和全身免疫炎症指数升高,这与自身免疫调节异常一致。
Front Immunol. 2024 Jan 22;14:1319947. doi: 10.3389/fimmu.2023.1319947. eCollection 2023.
7
Applications of Genome-Editing Technologies for Type 1 Diabetes.基因组编辑技术在 1 型糖尿病中的应用。
Int J Mol Sci. 2023 Dec 26;25(1):344. doi: 10.3390/ijms25010344.
8
Significant expansion of the donor pool achieved by utilizing islets of variable quality in the production of allogeneic "Neo-Islets", 3-D organoids of Mesenchymal Stromal and islet cells, a novel immune-isolating biotherapy for Type I Diabetes.通过利用质量不同的胰岛来生产同种异体“新胰岛”,即间充质基质和胰岛细胞的 3D 类器官,实现供体库的显著扩大,这是一种用于 1 型糖尿病的新型免疫隔离生物疗法。
PLoS One. 2023 Aug 24;18(8):e0290460. doi: 10.1371/journal.pone.0290460. eCollection 2023.
9
Banking on a new understanding: translational opportunities from veterinary biobanks.从兽医生物库中寻找新的理解:转化机会。
Geroscience. 2023 Jun;45(3):1439-1450. doi: 10.1007/s11357-023-00763-z. Epub 2023 Mar 8.
10
Canine induced pluripotent stem cells efficiently differentiate into definitive endoderm in 3D cell culture conditions using high-dose activin A.在三维细胞培养条件下,利用高剂量激活素A,犬诱导多能干细胞可高效分化为定形内胚层。
Regen Ther. 2022 Oct 26;21:502-510. doi: 10.1016/j.reth.2022.10.002. eCollection 2022 Dec.

本文引用的文献

1
Stem Cell-Derived Pancreatic Progenitor Cells Have Now Been Transplanted into Patients: Report from IPITA 2018.干细胞来源的胰腺祖细胞现已被移植到患者体内:来自2018年国际胰腺移植受者协会(IPITA)的报告。
Am J Transplant. 2018 Jul;18(7):1581-1582. doi: 10.1111/ajt.14954.
2
Pancreas regeneration.胰腺再生。
Nature. 2018 May;557(7705):351-358. doi: 10.1038/s41586-018-0088-0. Epub 2018 May 16.
3
Using Mesenchymal Stromal Cells in Islet Transplantation.应用间充质基质细胞进行胰岛移植。
Stem Cells Transl Med. 2018 Aug;7(8):559-563. doi: 10.1002/sctm.18-0033. Epub 2018 May 11.
4
Pancreas Transplantation for Patients with Type 1 and Type 2 Diabetes Mellitus in the United States: A Registry Report.美国 1 型和 2 型糖尿病患者的胰腺移植:登记报告。
Gastroenterol Clin North Am. 2018 Jun;47(2):417-441. doi: 10.1016/j.gtc.2018.01.009.
5
Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes.设计一种可回收和可扩展的细胞封装装置,用于潜在治疗 1 型糖尿病。
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E263-E272. doi: 10.1073/pnas.1708806115. Epub 2017 Dec 26.
6
Safety and immune regulatory properties of canine induced pluripotent stem cell-derived mesenchymal stem cells.犬诱导多能干细胞来源的间充质干细胞的安全性及免疫调节特性
Stem Cell Res. 2017 Dec;25:221-232. doi: 10.1016/j.scr.2017.11.010. Epub 2017 Nov 14.
7
The Big Pet Diabetes Survey: Perceived Frequency and Triggers for Euthanasia.大型宠物糖尿病调查:安乐死的感知频率与诱因
Vet Sci. 2017 May 14;4(2):27. doi: 10.3390/vetsci4020027.
8
The Diabetic Dog as a Translational Model for Human Islet Transplantation.糖尿病犬作为人类胰岛移植的转化模型
Yale J Biol Med. 2017 Sep 25;90(3):509-515. eCollection 2017 Sep.
9
Improved yield of canine islet isolation from deceased donors.提高从已故供体中分离犬胰岛的产量。
BMC Vet Res. 2017 Aug 22;13(1):264. doi: 10.1186/s12917-017-1177-2.
10
Bioprinting and Cellular Therapies for Type 1 Diabetes.生物打印和细胞疗法治疗 1 型糖尿病。
Trends Biotechnol. 2017 Nov;35(11):1025-1034. doi: 10.1016/j.tibtech.2017.07.006. Epub 2017 Aug 5.